1. Home
  2. Labeler Index
  3. Ther-rx Corporation
  4. NDC Product Code: 64011-010 Micro-k Extencaps

NDC 64011-010 Micro-k Extencaps

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 64011-010?
  5. Micro-k Extencaps Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
64011-010
Proprietary Name:
Micro-k Extencaps
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Ther-rx Corporation
Labeler Code:
64011
Product Label ID:
cb128705-d8c7-4341-a976-d8fd7371df6d
Start Marketing Date: [9]
08-01-2009
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
ORANGE (C48331 - ORANGE)
Shape:
CAPSULE (C48336)
Size(s):
23 MM
Imprint(s):
MICRO;K;THER;RX;010
Score:
1

Product Packages

NDC Code 64011-010-04

Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

NDC Code 64011-010-08

Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

NDC Code 64011-010-11

Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK

Product Details

What is NDC 64011-010?

The NDC code 64011-010 is assigned by the FDA to the product Micro-k Extencaps which is product labeled by Ther-rx Corporation. The product's dosage form is . The product is distributed in 3 packages with assigned NDC codes 64011-010-04 100 capsule, extended release in 1 bottle , 64011-010-08 500 capsule, extended release in 1 bottle , 64011-010-11 100 capsule, extended release in 1 blister pack . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Micro-k Extencaps?

BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop e.g., digitalized patients or patients with significant cardiac arrhythmias, hepatic cirrhosis with ascites, states of aldosterone excess with normal renal function, potassium-losing nephropathy, and certain diarrheal states. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern and when low doses of the diuretic are used. Serum potassium should be checked periodically, however, and if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. In more severe cases, and if dose adjustment of the diuretic is ineffective or unwarranted, supplementation with potassium salts may be indicated.

Which are Micro-k Extencaps UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Micro-k Extencaps Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Micro-k Extencaps?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 208939 - Micro-K Extencaps 8 MEQ Extended Release Oral Capsule
  • RxCUI: 208939 - potassium chloride 8 MEQ Extended Release Oral Capsule [Micro-K]
  • RxCUI: 208939 - K+ Chloride 8 MEQ Extended Release Oral Capsule [Micro-K]
  • RxCUI: 208939 - Micro-K 8 MEQ Extended Release Oral Capsule
  • RxCUI: 208939 - Pot Chloride 8 MEQ Extended Release Oral Capsule [Micro-K]

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".